javier pinilla-ibarz, md, phd: additional chemo-immunotherapy
Published 8 years ago • 59 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
0:45
javier pinilla-ibarz, md, phd: options to prolong survival
-
1:08
javier pinilla-ibarz, md, phd - malignant hematology
-
0:47
javier pinilla-ibarz, md, phd: dose intensity
-
0:59
javier pinilla-ibarz, md, phd: principle treatment options for patients with a 17p deletion
-
1:12
javier pinilla-ibarz, md, phd: treatment options for patients with previously treated cll
-
0:42
javier pinilla-ibarz, md, phd: bendamustine/rituximab therapy
-
0:54
javier pinilla-ibarz, md, phd: significance of treat to progression
-
0:47
javier pinilla-ibarz, md, phd: relapse following purine analog therapy
-
42:48
sitc president patrick hwu, md, fireside chat w/nci senior investigator steven a. rosenberg, md, phd
-
42:04
fireside chat with sitc president dr. patrick hwu, dr. mario sznol and dr. jedd wolchok
-
4:49
immunotherapy treatment faqs
-
0:31
javier pinilla-ibarz, md, phd: phase iii data to support usage of bruton's tkis
-
0:59
javier pinilla-ibarz, md, phd: use of bruton's tyrosine kinase inhibitor
-
1:48
dr. pinilla-ibarz on the role of chemotherapy in cll
-
0:52
dr. pinilla-ibarz discusses advancements in cml
-
0:55
dr. pinilla-ibarz on ibrutinib's efficacy in treating high-risk patients with cll
-
1:21
immunotherapy and targeted treatment for mnsclc | neal ready, md, phd | esmo22 pennsylvania
-
1:14
dr. pinilla-ibarz on the impact of venetoclax in cll
-
1:24
how ibrutinib has transformed the treatment paradigm of cll
-
31:47
la cats seminar series - a new druggable pathway for cancer immunotherapy - lucio miele, md, phd
-
2:26
cancer research institute: saving more lives with immunotherapy
-
5:06
treatment-free remission in cml